Istradefylline
Istradefylline is an adenosine A2A receptor antagonist primarily used as an adjunctive treatment for Parkinson's disease to improve motor function. By modulating adenosine pathways, it may offer cognitive benefits and neuroprotection, which are relevant for longevity and health optimization.
Member access required
Clinical protocols and outcomes data are available to AXIFI Members and Providers.